{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:43:19Z","timestamp":1792651399269,"version":"4.5.0"},"reference-count":217,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1111\/apt.13497","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T01:23:07Z","timestamp":1450833787000},"page":"514-533","source":"Crossref","is-referenced-by-count":684,"title":["Review article: the global emergence of\n                    <i>Helicobacter pylori<\/i>\n                    antibiotic resistance"],"prefix":"10.1111","volume":"43","author":[{"given":"I.","family":"Thung","sequence":"first","affiliation":[{"name":"Division of Anatomic Pathology; Department of Pathology; University of California San Diego Medical Center; San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Aramin","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology; Department of Pathology; University of California San Diego Medical Center; San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vavinskaya","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology; Department of Pathology; University of California San Diego Medical Center; San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology; Department of Medicine; University of California San Diego Medical Center; La Jolla CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Y.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology and the Eugene McDermott Center for Human Growth and Development; University of Texas Southwestern Medical Center and Children's Medical Center; Dallas TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Crowe","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology; Department of Medicine; University of California San Diego Medical Center; La Jolla CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Valasek","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology; Department of Pathology; University of California San Diego Medical Center; San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"key":"10.1111\/apt.13497-BIB0001|apt13497-cit-0001","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection-the Maastricht IV\/Florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"11 Suppl.","key":"10.1111\/apt.13497-BIB0002|apt13497-cit-0002","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0002-9270(99)00657-7","article-title":"Helicobacter pylori: from the benign to the malignant","volume":"94","author":"Williams","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0003|apt13497-cit-0003","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI20925","article-title":"Helicobacter pylori persistence: biology and disease","volume":"113","author":"Blaser","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1111\/apt.13497-BIB0004|apt13497-cit-0004","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0031-1291491","article-title":"Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa","volume":"44","author":"Dinis-Ribeiro","year":"2012","journal-title":"Endoscopy"},{"key":"10.1111\/apt.13497-BIB0005|apt13497-cit-0005","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/apt.13497-BIB0006|apt13497-cit-0006","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/j.gastro.2007.07.008","article-title":"Eradication therapy for Helicobacter pylori","volume":"133","author":"Vakil","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.13497-BIB0007|apt13497-cit-0007","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","article-title":"Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial","volume":"372","author":"Fukase","year":"2008","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1111\/apt.13497-BIB0008|apt13497-cit-0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1523-5378.2012.00983.x","article-title":"Extragastric manifestations of Helicobacter pylori infection","volume":"17","author":"Bani\u0107","year":"2012","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0009|apt13497-cit-0009","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/hel.12014","article-title":"Relationship between Helicobacter pylori infection and serum interleukin-18 in patients with carotid atherosclerosis","volume":"18","author":"Chen","year":"2013","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0010|apt13497-cit-0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/oxfordjournals.epirev.a018040","article-title":"Helicobacter pylori: epidemiology and routes of transmission","volume":"22","author":"Brown","year":"2000","journal-title":"Epidemiol Rev"},{"key":"10.1111\/apt.13497-BIB0011|apt13497-cit-0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijfoodmicro.2010.01.016","article-title":"Transmission pathway of Helicobacter pylori: does food play a role in rural and urban areas?","volume":"138","author":"Vale","year":"2010","journal-title":"Int J Food Microbiol"},{"key":"10.1111\/apt.13497-BIB0012|apt13497-cit-0012","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1757-4749-2-2","article-title":"Helicobacter pylori: a poor man's gut pathogen?","volume":"2","author":"Khalifa","year":"2010","journal-title":"Gut Pathog"},{"key":"10.1111\/apt.13497-BIB0013|apt13497-cit-0013","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4269\/ajtmh.1999.61.37","article-title":"Seroprevalence of Helicobacter pylori among Egyptian newborns and their mothers: a preliminary report","volume":"61","author":"Bassily","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/apt.13497-BIB0014|apt13497-cit-0014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1523-5378.2005.00317.x","article-title":"Children of Helicobacter pylori-infected dyspeptic mothers are predisposed to H. pylori acquisition with subsequent iron deficiency and growth retardation","volume":"10","author":"Yang","year":"2005","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0015|apt13497-cit-0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1017\/S0950268805003900","article-title":"Helicobacter pylori status in family members as risk factors for infection in children","volume":"133","author":"Kivi","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1111\/apt.13497-BIB0016|apt13497-cit-0016","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ajg.2008.61","article-title":"Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings","volume":"104","author":"Weyermann","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0017|apt13497-cit-0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00005176-200010000-00014","article-title":"Helicobacter pylori infection in children of Texas","volume":"31","author":"Opekun","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/apt.13497-BIB0018|apt13497-cit-0018","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.2002.01276.x","article-title":"Review article: Helicobacter pylori \u201crescue\u201d regimen when proton pump inhibitor-based triple therapies fail","volume":"16","author":"Gisbert","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0019|apt13497-cit-0019","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s100960100611","article-title":"European multicentre survey of in\u00a0vitro antimicrobial resistance in Helicobacter pylori","volume":"20","author":"Glupczynski","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/apt.13497-BIB0020|apt13497-cit-0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ncpgasthep1138","article-title":"New concepts of resistance in the treatment of Helicobacter pylori infections","volume":"5","author":"Graham","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0021|apt13497-cit-0021","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1523-5378.2005.00324.x","article-title":"Helicobacter pylori \u201crescue\u201d therapy after failure of two eradication treatments","volume":"10","author":"Gisbert","year":"2005","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0022|apt13497-cit-0022","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0023|apt13497-cit-0023","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MOG.0b013e32834bb818","article-title":"Treatment of Helicobacter pylori","volume":"27","author":"Selgrad","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0024|apt13497-cit-0024","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/eri.09.113","article-title":"Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents","volume":"8","author":"Boyanova","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/apt.13497-BIB0025|apt13497-cit-0025","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0026|apt13497-cit-0026","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1590-8658(03)00081-1","article-title":"A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?","volume":"35","author":"Zullo","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.13497-BIB0027|apt13497-cit-0027","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.320.7226.31","article-title":"Regular review: treatment of Helicobacter pylori infection","volume":"320","author":"Boer","year":"2000","journal-title":"BMJ"},{"key":"10.1111\/apt.13497-BIB0028|apt13497-cit-0028","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0025-7753(01)71783-6","article-title":"Therapeutic strategies in Helicobacter pylori infection","volume":"116","author":"Calvet","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1111\/apt.13497-BIB0029|apt13497-cit-0029","first-page":"299","article-title":"Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline","volume":"20","author":"Hunt","year":"2011","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1111\/apt.13497-BIB0030|apt13497-cit-0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/hel.12061","article-title":"Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults","volume":"18","author":"Bastos","year":"2013","journal-title":"Helicobacter"},{"issue":"Suppl. 1","key":"10.1111\/apt.13497-BIB0031|apt13497-cit-0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2008.00631.x","article-title":"Epidemiology of Helicobacter pylori infection","volume":"13","author":"Bruce","year":"2008","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0032|apt13497-cit-0032","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1523-5378.2007.00488.x","article-title":"Intrafamilial transmission of Helicobacter pylori among the population of endemic areas in Japan","volume":"12","author":"Fujimoto","year":"2007","journal-title":"Helicobacter"},{"issue":"Suppl. 1","key":"10.1111\/apt.13497-BIB0033|apt13497-cit-0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2010.00779.x","article-title":"Epidemiology of Helicobacter pylori infection and public health implications","volume":"15","author":"Ford","year":"2010","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0034|apt13497-cit-0034","first-page":"497","article-title":"[Prevalence of Helicobacter pylori infection in the healthy population of Madrid (Spain)]","volume":"99","author":"S\u00e1nchez Ceballos","year":"2007","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1111\/apt.13497-BIB0035|apt13497-cit-0035","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.3748\/wjg.v20.i13.3635","article-title":"Seroepidemiology of Helicobacter pylori infection in elderly people in the Beijing region, China","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0036|apt13497-cit-0036","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1572-0241.1999.01283.x","article-title":"Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20\u00a0years in Japan","volume":"94","author":"Fujisawa","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0037|apt13497-cit-0037","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.3748\/wjg.v20.i16.4483","article-title":"Characteristics of gastric cancer in Asia","volume":"20","author":"Rahman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0038|apt13497-cit-0038","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ije\/27.4.570","article-title":"Helicobacter pylori infection and mode of transmission in a population at high risk of stomach cancer","volume":"27","author":"Ma","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1111\/apt.13497-BIB0039|apt13497-cit-0039","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1440-1746.2009.06188.x","article-title":"Epidemiology of Helicobacter pylori infection and gastric cancer in Asia","volume":"25","author":"Fock","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0040|apt13497-cit-0040","first-page":"176","article-title":"A seroepidemiologic study of Helicobacter pylori and hepatitis A virus infection in primary school students in Taipei","volume":"38","author":"Lin","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/apt.13497-BIB0041|apt13497-cit-0041","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1523-5378.2007.00504.x","article-title":"Seroprevalence of Helicobacter pylori in South Korea","volume":"12","author":"Yim","year":"2007","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0042|apt13497-cit-0042","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-230X-13-104","article-title":"Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13\u00a0years","volume":"13","author":"Lim","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0043|apt13497-cit-0043","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00042737-199612000-00006","article-title":"Helicobacter pylori infection in a healthy population in Spain","volume":"8","author":"Mart\u00edn-de-Argila","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0044|apt13497-cit-0044","first-page":"241","article-title":"Prevalence of Helicobacter pylori infection in the general adult population of the province of Ourense","volume":"98","author":"Macenlle Garc\u00eda","year":"2006","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1111\/apt.13497-BIB0045|apt13497-cit-0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1477-7819-6-74","article-title":"Helicobacter pylori and gastroesophageal reflux disease","volume":"6","author":"Grande","year":"2008","journal-title":"World J Surg Oncol"},{"key":"10.1111\/apt.13497-BIB0046|apt13497-cit-0046","first-page":"69","article-title":"Helicobacter pylori and gastroesophageal reflux disease: a cross sectional study","volume":"58","author":"Scarpa","year":"2011","journal-title":"Hepatogast-roenterology"},{"key":"10.1111\/apt.13497-BIB0047|apt13497-cit-0047","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.3748\/wjg.v19.i45.8168","article-title":"How antibiotic resistances could change Helicobacter pylori treatment: a matter of geography?","volume":"19","author":"Ierardi","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0048|apt13497-cit-0048","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1523-5378.2006.00414.x","article-title":"Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population","volume":"11","author":"Storskrubb","year":"2006","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0049|apt13497-cit-0049","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/JCM.41.9.4038-4042.2003","article-title":"Unexpected decrease with age of Helicobacter pylori seroprevalence among Swedish blood donors","volume":"41","author":"S\u00f6rberg","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/apt.13497-BIB0050|apt13497-cit-0050","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/014107689709001031","article-title":"Helicobacters in Bulgarian children","volume":"90","author":"Boyanova","year":"1997","journal-title":"J R Soc Med"},{"key":"10.1111\/apt.13497-BIB0051|apt13497-cit-0051","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0163-4453(98)80169-2","article-title":"Seroprevalence of Helicobacter pylori infection in an asymptomatic Turkish population","volume":"37","author":"Us","year":"1998","journal-title":"J Infect"},{"key":"10.1111\/apt.13497-BIB0052|apt13497-cit-0052","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1186\/1471-2458-13-1215","article-title":"Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the 13C-Urea breath test","volume":"13","author":"Ozaydin","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1111\/apt.13497-BIB0053|apt13497-cit-0053","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/aje\/kwr288","article-title":"Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race\/ethnic disparities","volume":"175","author":"Grad","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1111\/apt.13497-BIB0054|apt13497-cit-0054","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<453::AID-IJC13>3.0.CO;2-D","article-title":"Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections","volume":"72","author":"P\u00e9rez-P\u00e9rez","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1111\/apt.13497-BIB0055|apt13497-cit-0055","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1023\/A:1026689103952","article-title":"Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population","volume":"44","author":"Bernstein","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.13497-BIB0056|apt13497-cit-0056","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/infdis\/jis106","article-title":"Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels","volume":"205","author":"Chen","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1111\/apt.13497-BIB0057|apt13497-cit-0057","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-136-1-200201010-00008","article-title":"Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori\u00a0antimicrobial resistance partnership (SHARP) study, 1993-1999","volume":"136","author":"Meyer","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/apt.13497-BIB0058|apt13497-cit-0058","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.gastro.2015.01.040","article-title":"Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits","volume":"148","author":"Graham","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.13497-BIB0059|apt13497-cit-0059","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.gastro.2012.05.012","article-title":"Which therapy for Helicobacter pylori infection?","volume":"143","author":"Graham","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.13497-BIB0060|apt13497-cit-0060","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.3748\/wjg.v17.i35.3971","article-title":"A new look at anti-Helicobacter pylori therapy","volume":"17","author":"Chuah","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0061|apt13497-cit-0061","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0062|apt13497-cit-0062","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/JCM.00740-07","article-title":"Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005","volume":"45","author":"Kobayashi","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/apt.13497-BIB0063|apt13497-cit-0063","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3201\/eid1006.030744","article-title":"Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States","volume":"10","author":"Duck","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/apt.13497-BIB0064|apt13497-cit-0064","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1523-5378.2002.00096.x","article-title":"The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance","volume":"7","author":"Perez","year":"2002","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0065|apt13497-cit-0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7326\/0003-4819-139-6-200309160-00008","article-title":"The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections","volume":"139","author":"McMahon","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/apt.13497-BIB0066|apt13497-cit-0066","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1523-5378.2006.00462.x","article-title":"Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003","volume":"11","author":"Bruce","year":"2006","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0067|apt13497-cit-0067","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1086\/510074","article-title":"The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection","volume":"44","author":"Carothers","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/apt.13497-BIB0068|apt13497-cit-0068","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2012.05083.x","article-title":"Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?","volume":"35","author":"McNulty","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0069|apt13497-cit-0069","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(00)04972-2","article-title":"Variation in antibiotic use in the European Union","volume":"357","author":"Cars","year":"2001","journal-title":"Lancet (London, England)"},{"key":"10.1111\/apt.13497-BIB0070|apt13497-cit-0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1523-5378.2009.00714.x","article-title":"Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan","volume":"14","author":"Horiki","year":"2009","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0071|apt13497-cit-0071","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/hel.12124","article-title":"Antimicrobial resistance and characteristics of eradication therapy of Helicobacter pylori in Japan: a multi-generational comparison","volume":"19","author":"Okamura","year":"2014","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0072|apt13497-cit-0072","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1523-5378.2010.00788.x","article-title":"The evolution of Helicobacter pylori antibiotics resistance over 10\u00a0years in Beijing, China","volume":"15","author":"Gao","year":"2010","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0073|apt13497-cit-0073","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3748\/wjg.v21.i9.2786","article-title":"Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0074|apt13497-cit-0074","first-page":"409","article-title":"Worldwide H. pylori antibiotic resistance: a systematic review","volume":"19","author":"De Francesco","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1111\/apt.13497-BIB0075|apt13497-cit-0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/hel.12176","article-title":"Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial","volume":"20","author":"Tsay","year":"2015","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0076|apt13497-cit-0076","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jac\/47.4.459","article-title":"Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea","volume":"47","author":"Kim","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/apt.13497-BIB0077|apt13497-cit-0077","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MCG.0b013e3181d04592","article-title":"Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea","volume":"44","author":"Hwang","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0078|apt13497-cit-0078","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/AAC.49.4.1600-1603.2005","article-title":"Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults","volume":"49","author":"Lee","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0079|apt13497-cit-0079","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H pylori antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"M\u00e9graud","year":"2004","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0080|apt13497-cit-0080","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1128\/JCM.00144-10","article-title":"High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain","volume":"48","author":"Agudo","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/apt.13497-BIB0081|apt13497-cit-0081","first-page":"363","article-title":"High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy","volume":"21","author":"Saracino","year":"2012","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1111\/apt.13497-BIB0082|apt13497-cit-0082","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2010.03.010","article-title":"Two-decade trends in primary Helicobacter pylori resistance to antibiotics in Bulgaria","volume":"67","author":"Boyanova","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/apt.13497-BIB0083|apt13497-cit-0083","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.diagmicrobio.2014.03.028","article-title":"Helicobacter pylori susceptibility to fosfomycin, rifampin, and 5 usual antibiotics for H. pylori eradication","volume":"79","author":"Boyanova","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/apt.13497-BIB0084|apt13497-cit-0084","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.161.9.1217","article-title":"Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States","volume":"161","author":"Osato","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/apt.13497-BIB0085|apt13497-cit-0085","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2015.02.005","article-title":"Antibiotic resistance of Helicobacter pylori among male United States Veterans","volume":"13","author":"Shiota","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0086|apt13497-cit-0086","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MPG.0000000000000380","article-title":"Novel Helicobacter pylori sequencing test identifies high rate of clarithromycin resistance","volume":"59","author":"Mitui","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/apt.13497-BIB0087|apt13497-cit-0087","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3343\/alm.2013.33.6.415","article-title":"Antibiotic resistance in Helicobacter pylori strains and its effect on H. pylori eradication rates in a single center in Korea","volume":"33","author":"An","year":"2013","journal-title":"Ann Lab Med"},{"key":"10.1111\/apt.13497-BIB0088|apt13497-cit-0088","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1440-1746.2009.05829.x","article-title":"Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan","volume":"24","author":"Chang","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0089|apt13497-cit-0089","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1440-1746.2011.06874.x","article-title":"Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance","volume":"27","author":"Chung","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0090|apt13497-cit-0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jac\/dkr410","article-title":"Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain","volume":"67","author":"Cuadrado-Lavin","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/apt.13497-BIB0091|apt13497-cit-0091","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0924-8579(00)00205-3","article-title":"Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period","volume":"16","author":"Ferrero","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/apt.13497-BIB0092|apt13497-cit-0092","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1348-0421.1997.tb01166.x","article-title":"Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy","volume":"41","author":"Gotoh","year":"1997","journal-title":"Microbiol Immunol"},{"key":"10.1111\/apt.13497-BIB0093|apt13497-cit-0093","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1046\/j.1440-1746.2003.03140.x","article-title":"Prevalence of Helicobacter pylori resistance to clarithromycin and metronidazole determined by 23S ribosomal RNA and rdxA gene analyses in Hiroshima, Japan","volume":"18","author":"Hiyama","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0094|apt13497-cit-0094","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1128\/AAC.44.8.2214-2216.2000","article-title":"Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan","volume":"44","author":"Kato","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0095|apt13497-cit-0095","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00004836-200609000-00004","article-title":"Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea","volume":"40","author":"Kim","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0096|apt13497-cit-0096","doi-asserted-by":"crossref","first-page":"e0124199","DOI":"10.1371\/journal.pone.0124199","article-title":"The primary resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study","volume":"10","author":"Liou","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1111\/apt.13497-BIB0097|apt13497-cit-0097","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/jac\/40.2.279","article-title":"Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain","volume":"40","author":"L\u00f3pez-Brea","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/apt.13497-BIB0098|apt13497-cit-0098","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/48.2.295","article-title":"A 9\u00a0year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children","volume":"48","author":"L\u00f3pez-Brea","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/apt.13497-BIB0099|apt13497-cit-0099","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1572-0241.2003.07681.x","article-title":"Susceptibility of Helicobacter pylori to metronidazole","volume":"98","author":"Perna","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0100|apt13497-cit-0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1590-8658(00)80352-7","article-title":"Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer","volume":"32","author":"Pilotto","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.13497-BIB0101|apt13497-cit-0101","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijantimicag.2009.02.007","article-title":"Prevalence of antimicrobial resistance in Helicobacter pylori isolates in Taiwan in relation to consumption of antimicrobial agents","volume":"34","author":"Poon","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/apt.13497-BIB0102|apt13497-cit-0102","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1523-5378.1999.99002.x","article-title":"Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies","volume":"4","author":"Realdi","year":"1999","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0103|apt13497-cit-0103","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1099\/0022-1317-49-5-415","article-title":"Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria","volume":"49","author":"Boyanova","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1111\/apt.13497-BIB0104|apt13497-cit-0104","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diagmicrobio.2007.11.008","article-title":"Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12\u00a0years and correlation between susceptibility testing methods","volume":"60","author":"Boyanova","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/apt.13497-BIB0105|apt13497-cit-0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1083-4389.2004.00230.x","article-title":"Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication","volume":"9","author":"Ozcay","year":"2004","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0106|apt13497-cit-0106","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/0037-8682-0027-2015","article-title":"Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey","volume":"48","author":"Caliskan","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1111\/apt.13497-BIB0107|apt13497-cit-0107","first-page":"327","volume-title":"Surveillance Nationale des Maladies Infectieuses 1998-2000","author":"Megraud","year":"2003"},{"key":"10.1111\/apt.13497-BIB0108|apt13497-cit-0108","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1099\/0022-1317-51-8-705","article-title":"Antibiotic susceptibility of Helicobacter pylori in Germany: stable\u00a0primary resistance from 1995 to\u00a02000","volume":"51","author":"Wolle","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1111\/apt.13497-BIB0109|apt13497-cit-0109","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1590-8658(03)00265-2","article-title":"Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002","volume":"35","author":"Toracchio","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.13497-BIB0110|apt13497-cit-0110","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/JCM.39.7.2677-2680.2001","article-title":"Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico","volume":"39","author":"Torres","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/apt.13497-BIB0111|apt13497-cit-0111","first-page":"448","article-title":"The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication-a randomised controlled trial","volume":"114","author":"Bago","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"10.1111\/apt.13497-BIB0112|apt13497-cit-0112","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1155\/2000\/562159","article-title":"Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada","volume":"14","author":"Fallone","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0113|apt13497-cit-0113","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0213-005X(02)72778-X","article-title":"[Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment]","volume":"20","author":"Cuch\u00ed Burgos","year":"2002","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/apt.13497-BIB0114|apt13497-cit-0114","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1046\/j.1365-2036.2001.01068.x","article-title":"Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status","volume":"15","author":"Parsons","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0115|apt13497-cit-0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1523-5378.2002.00101_1.x","article-title":"The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001)","volume":"7","author":"Ling","year":"2002","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0116|apt13497-cit-0116","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jac\/46.6.1029","article-title":"Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999)","volume":"46","author":"Cabrita","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/apt.13497-BIB0117|apt13497-cit-0117","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dki334","article-title":"Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients","volume":"56","author":"Kim","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/apt.13497-BIB0118|apt13497-cit-0118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000112416","article-title":"Levofloxacin-Resistant Helicobacter pylori in Hong Kong","volume":"54","author":"Lee","year":"2008","journal-title":"Chemotherapy"},{"key":"10.1111\/apt.13497-BIB0119|apt13497-cit-0119","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/hel.12052","article-title":"Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy","volume":"18","author":"Liao","year":"2013","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0120|apt13497-cit-0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1523-5378.2006.00415.x","article-title":"Primary levofloxacin resistance and gyrA\/B mutations among Helicobacter pylori in Japan","volume":"11","author":"Miyachi","year":"2006","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0121|apt13497-cit-0121","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.3748\/wjg.v16.i40.5118","article-title":"Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai","volume":"16","author":"Sun","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0122|apt13497-cit-0122","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/43.4.511","article-title":"Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands","volume":"43","author":"Debets-Ossenkopp","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/apt.13497-BIB0123|apt13497-cit-0123","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1128\/AAC.47.12.3942-3944.2003","article-title":"Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori","volume":"47","author":"Tankovic","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0124|apt13497-cit-0124","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1469-0691.2002.00435.x","article-title":"The status of antimicrobial resistance of Helicobacter pylori in eastern Europe","volume":"8","author":"Boyanova","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/apt.13497-BIB0125|apt13497-cit-0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/apt.13280","article-title":"High Helicobacter pylori cure rate with sitafloxacin-based triple therapy","volume":"42","author":"Sugimoto","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0126|apt13497-cit-0126","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3748\/wjg.v20.i6.1517","article-title":"Second and third line treatment options for Helicobacter pylori eradication","volume":"20","author":"Song","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0127|apt13497-cit-0127","doi-asserted-by":"crossref","first-page":"16245","DOI":"10.3748\/wjg.v20.i43.16245","article-title":"Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection","volume":"20","author":"Selgrad","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0128|apt13497-cit-0128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-230X-3-20","article-title":"Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates","volume":"3","author":"Godoy","year":"2003","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0129|apt13497-cit-0129","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3346\/jkms.2014.29.9.1240","article-title":"Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea","volume":"29","author":"Yoon","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1111\/apt.13497-BIB0130|apt13497-cit-0130","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/AAC.46.7.2229-2233.2002","article-title":"Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori","volume":"46","author":"Gerrits","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0131|apt13497-cit-0131","first-page":"608","article-title":"Helicobacter pylori-the latest in diagnosis and treatment","volume":"37","author":"Stenstr\u00f6m","year":"2008","journal-title":"Aust Fam Physician"},{"issue":"Pt B","key":"10.1111\/apt.13497-BIB0132|apt13497-cit-0132","first-page":"1","article-title":"Volume 100 B. A review of human carcinogens","volume":"100","author":"Biological agents","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1111\/apt.13497-BIB0133|apt13497-cit-0133","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0134|apt13497-cit-0134","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","article-title":"Guidelines for\u00a0the management of dyspepsia","volume":"100","author":"Talley","year":"2005","journal-title":"Am J\u00a0Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0135|apt13497-cit-0135","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bmj.326.7399.1118","article-title":"Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment","volume":"326","author":"Manes","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/apt.13497-BIB0136|apt13497-cit-0136","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/jech.54.6.444","article-title":"Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study","volume":"54","author":"Rosenstock","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"10.1111\/apt.13497-BIB0137|apt13497-cit-0137","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/jcp.47.3.286-b","article-title":"Seroconversion for Helicobacter pylori","volume":"47","author":"Oderda","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1111\/apt.13497-BIB0138|apt13497-cit-0138","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/oxfordjournals.aje.a008694","article-title":"Seroprevalence of immunoglobulin G, M, and A antibodies to Helicobacter pylori in an unselected Danish population","volume":"143","author":"Andersen","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1111\/apt.13497-BIB0139|apt13497-cit-0139","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/CVI.00149-09","article-title":"Evaluation of Helicobacter pylori immunoglobulin G (IgG), IgA, and IgM serologic testing compared to stool antigen testing","volume":"16","author":"She","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl. 1","key":"10.1111\/apt.13497-BIB0140|apt13497-cit-0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2036.11.s1.3.x","article-title":"Non-endoscopic tests in the diagnosis of Helicobacter pylori infection","volume":"11","author":"Atherton","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0141|apt13497-cit-0141","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/j.1365-2036.2006.02936.x","article-title":"Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy","volume":"23","author":"Dom\u00ednguez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0142|apt13497-cit-0142","first-page":"301","article-title":"Helicobacter pylori eradication - an update on the latest therapies","volume":"43","author":"Yaxley","year":"2014","journal-title":"Aust Fam Physician"},{"key":"10.1111\/apt.13497-BIB0143|apt13497-cit-0143","first-page":"9299","article-title":"Helicobacter pylori infection - recent developments in diagnosis","volume":"20","author":"Lopes","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0144|apt13497-cit-0144","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00042737-199601000-00010","article-title":"Modified rapid urease test for detection of Helicobacter pylori infection","volume":"8","author":"Malfertheiner","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0145|apt13497-cit-0145","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/apt.13497-BIB0146|apt13497-cit-0146","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1365-2036.2000.00844.x","article-title":"Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori","volume":"14","author":"Gisbert","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0147|apt13497-cit-0147","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.3748\/wjg.v20.i18.5252","article-title":"Attempts to enhance the eradication rate of Helicobacter pylori infection","volume":"20","author":"Bang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0148|apt13497-cit-0148","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts\u00a0in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0149|apt13497-cit-0149","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cgh.2013.05.028","article-title":"Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence","volume":"12","author":"Graham","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0150|apt13497-cit-0150","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0151|apt13497-cit-0151","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1523-5378.2006.00459.x","article-title":"2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study","volume":"11","author":"Paoluzi","year":"2006","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0152|apt13497-cit-0152","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Clinical practice. Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/apt.13497-BIB0153|apt13497-cit-0153","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","article-title":"Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori","volume":"26","author":"Fischbach","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0154|apt13497-cit-0154","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1523-5378.2010.00758.x","article-title":"High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication","volume":"15","author":"Sun","year":"2010","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0155|apt13497-cit-0155","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/00042737-200012120-00008","article-title":"Limited usefulness of a seven-day twice-a-day quadruple therapy","volume":"12","author":"Garcia","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0156|apt13497-cit-0156","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1083-4389.2002.00066.x","article-title":"Amoxicillin\/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection","volume":"7","author":"Perri","year":"2002","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0157|apt13497-cit-0157","first-page":"273","article-title":"Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients","volume":"53","author":"Wang","year":"2012","journal-title":"Singapore Med J"},{"key":"10.1111\/apt.13497-BIB0158|apt13497-cit-0158","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejim.2008.04.003","article-title":"The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication","volume":"20","author":"Akyildiz","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1111\/apt.13497-BIB0159|apt13497-cit-0159","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/apt.13497-BIB0160|apt13497-cit-0160","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/gut.2010.215350","article-title":"Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial","volume":"59","author":"Romano","year":"2010","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0161|apt13497-cit-0161","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/dkg050","article-title":"The importance of efflux pumps in bacterial antibiotic resistance","volume":"51","author":"Webber","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/apt.13497-BIB0162|apt13497-cit-0162","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1523-5378.2009.00671.x","article-title":"Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing \u201cconcomitant therapy\u201d versus triple therapy for Helicobacter pylori eradication","volume":"14","author":"Essa","year":"2009","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0163|apt13497-cit-0163","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/MCG.0b013e31826015b0","article-title":"Nonbismuth quadruple \u201cconcomitant\u201d therapy versus standard triple therapy, both of the duration of 10\u00a0days, for first-line H. pylori eradication: a randomized trial","volume":"47","author":"Georgopoulos","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0164|apt13497-cit-0164","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2009.09.030","article-title":"Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.13497-BIB0165|apt13497-cit-0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/j.gastro.2012.03.043","article-title":"Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection","volume":"143","author":"Federico","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.13497-BIB0166|apt13497-cit-0166","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1523-5378.2012.00953.x","article-title":"Pilot studies to\u00a0identify the optimum duration of\u00a0concomitant Helicobacter pylori\u00a0eradication therapy in Thailand","volume":"17","author":"Kongchayanun","year":"2012","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0167|apt13497-cit-0167","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1523-5378.2011.00828.x","article-title":"Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14\u00a0days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7\u00a0days","volume":"16","author":"Hsu","year":"2011","journal-title":"Helicobacter"},{"issue":"Suppl. 3","key":"10.1111\/apt.13497-BIB0168|apt13497-cit-0168","first-page":"A47","article-title":"14-day, high-dose acid suppression, non-bismuth quadruple therapies (\u201chybrid\u201d vs. \u201cconcomitant\u201d) for Helicobacter pylori infection: a randomized trial","volume":"61","author":"Molina-Infante","year":"2012","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0169|apt13497-cit-0169","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.gastro.2013.03.050","article-title":"Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance","volume":"145","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.13497-BIB0170|apt13497-cit-0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1756283X10384171","article-title":"Should quinolones come first in Helicobacter pylori therapy?","volume":"4","author":"Berning","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0171|apt13497-cit-0171","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/ajg.2011.306","article-title":"A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori","volume":"106","author":"Basu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0172|apt13497-cit-0172","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2362.2008.01951.x","article-title":"Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures","volume":"38","author":"Hsu","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/apt.13497-BIB0173|apt13497-cit-0173","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3164\/jcbn.08-220R","article-title":"Quinolone-based third-line therapy\u00a0for Helicobacter pylori eradication","volume":"44","author":"Nishizawa","year":"2009","journal-title":"J Clin Biochem Nutr"},{"key":"10.1111\/apt.13497-BIB0174|apt13497-cit-0174","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2011.04937.x","article-title":"Review article: rifabutin in the treatment of refractory Helicobacter pylori infection","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13497-BIB0175|apt13497-cit-0175","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1128\/AEM.02470-08","article-title":"Development and application of a novel peptide nucleic acid probe for the specific detection of Cronobacter genomospecies (Enterobacter sakazakii) in powdered infant formula","volume":"75","author":"Almeida","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1111\/apt.13497-BIB0176|apt13497-cit-0176","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2125.2011.04048.x","article-title":"Effectiveness of three times daily lansoprazole\/amoxicillin dual therapy for Helicobacter pylori infection in Korea","volume":"73","author":"Kim","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/apt.13497-BIB0177|apt13497-cit-0177","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1523-5378.2007.00508.x","article-title":"Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy","volume":"12","author":"Sugimoto","year":"2007","journal-title":"Helicobacter"},{"key":"10.1111\/apt.13497-BIB0178|apt13497-cit-0178","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7704\/kjhugr.2012.12.4.219","article-title":"Recent trends of Helicobacter pylori eradication therapy in Korea","volume":"12","author":"Kim","year":"2012","journal-title":"Korean J Helicobacter Up Gastrointest Res"},{"key":"10.1111\/apt.13497-BIB0179|apt13497-cit-0179","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/mdr.2014.0019","article-title":"Evolution of amoxicillin resistance of Helicobacter pylori in\u00a0vitro: characterization of resistance mechanisms","volume":"20","author":"Qureshi","year":"2014","journal-title":"Microb Drug Resist"},{"key":"10.1111\/apt.13497-BIB0180|apt13497-cit-0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.18388\/abp.2014_1901","article-title":"PCR-RFLP detection of point mutations A2143G and A2142G in 23S rRNA gene conferring resistance to clarithromycin in Helicobacter pylori strains","volume":"61","author":"Klesiewicz","year":"2014","journal-title":"Acta Biochim Pol"},{"key":"10.1111\/apt.13497-BIB0181|apt13497-cit-0181","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2958.1998.00806.x","article-title":"Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase","volume":"28","author":"Goodwin","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1111\/apt.13497-BIB0182|apt13497-cit-0182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(01)00468-X","article-title":"Metronidazole resistance in Helicobacter pylori","volume":"19","author":"Jenks","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/apt.13497-BIB0183|apt13497-cit-0183","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/2277-9175.128469","article-title":"The mutation of the rdxA gene in metronidazole-resistant Helicobacter pylori clinical isolates","volume":"3","author":"Mirzaei","year":"2014","journal-title":"Adv Biomed Res"},{"key":"10.1111\/apt.13497-BIB0184|apt13497-cit-0184","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/AAC.46.9.2996-3000.2002","article-title":"16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori","volume":"46","author":"Gerrits","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0185|apt13497-cit-0185","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2006.11.007","article-title":"Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility","volume":"29","author":"Cattoir","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/apt.13497-BIB0186|apt13497-cit-0186","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/AAC.39.1.107","article-title":"Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori","volume":"39","author":"Moore","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0187|apt13497-cit-0187","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/AAC.01105-10","article-title":"Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in\u00a0vitro activity and resistance development","volume":"55","author":"Yamamoto","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0188|apt13497-cit-0188","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijantimicag.2011.12.002","article-title":"Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan","volume":"39","author":"Hirata","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/apt.13497-BIB0189|apt13497-cit-0189","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/AAC.43.6.1497","article-title":"Rifampin and rifabutin resistance mechanism in Helicobacter pylori","volume":"43","author":"Heep","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0190|apt13497-cit-0190","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/AAC.44.4.1075-1077.2000","article-title":"Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis","volume":"44","author":"Heep","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0191|apt13497-cit-0191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000191204","article-title":"Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori","volume":"79","author":"Suzuki","year":"2009","journal-title":"Digestion"},{"key":"10.1111\/apt.13497-BIB0192|apt13497-cit-0192","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/JCM.39.7.2648-2651.2001","article-title":"Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy","volume":"39","author":"Ende","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/apt.13497-BIB0193|apt13497-cit-0193","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.diagmicrobio.2011.05.002","article-title":"Practical use of GenoType\u00ae HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing","volume":"70","author":"Miendje Deyi","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/apt.13497-BIB0194|apt13497-cit-0194","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/10766290252913773","article-title":"Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori","volume":"8","author":"Grignon","year":"2002","journal-title":"Microb Drug Resist"},{"key":"10.1111\/apt.13497-BIB0195|apt13497-cit-0195","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/AAC.41.12.2634","article-title":"Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time","volume":"41","author":"Hartzen","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0196|apt13497-cit-0196","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s100960000340","article-title":"Assessment of optimal atmospheric conditions for growth of Helicobacter pylori","volume":"19","author":"Henriksen","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/apt.13497-BIB0197|apt13497-cit-0197","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing and Approved Standard M7-A5. Informational Supplement M100-S10","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1111\/apt.13497-BIB0198|apt13497-cit-0198","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0732-8893(95)00252-9","article-title":"Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole","volume":"24","author":"Hachem","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/apt.13497-BIB0199|apt13497-cit-0199","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-0711-3-25","article-title":"Laboratory diagnosis and susceptibility profile of Helicobacter\u00a0pylori infection in the Philippines","volume":"3","author":"Destura","year":"2004","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1111\/apt.13497-BIB0200|apt13497-cit-0200","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10096-002-0757-6","article-title":"Comparison of the E test and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori","volume":"21","author":"Glupczynski","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/apt.13497-BIB0201|apt13497-cit-0201","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3748\/wjg.v13.i5.671","article-title":"Clinical role and importance of fluorescence in\u00a0situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy","volume":"13","author":"Yilmaz","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.13497-BIB0202|apt13497-cit-0202","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1128\/JCM.02352-07","article-title":"Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori","volume":"46","author":"Burucoa","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/apt.13497-BIB0203|apt13497-cit-0203","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.45.5.1500-1504.2001","article-title":"Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study","volume":"45","author":"Doorn","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/apt.13497-BIB0204|apt13497-cit-0204","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1128\/JCM.42.10.4512-4518.2004","article-title":"Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens","volume":"42","author":"Schabereiter-Gurtner","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/apt.13497-BIB0205|apt13497-cit-0205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.00033-06","article-title":"Helicobacter pylori detection and antimicrobial susceptibility testing","volume":"20","author":"M\u00e9graud","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/apt.13497-BIB0206|apt13497-cit-0206","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1128\/JCM.39.11.4142-4144.2001","article-title":"Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in\u00a0situ hybridization","volume":"39","author":"R\u00fcssmann","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/apt.13497-BIB0207|apt13497-cit-0207","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2672.2001.01230.x","article-title":"Filter-based PNA in\u00a0situ hybridization for rapid detection, identification and enumeration of specific micro-organisms","volume":"90","author":"Perry-O'Keefe","year":"2001","journal-title":"J Appl Microbiol"},{"key":"10.1111\/apt.13497-BIB0208|apt13497-cit-0208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-7012(01)00340-2","article-title":"PNA for rapid microbiology","volume":"48","author":"Stender","year":"2002","journal-title":"J Microbiol Methods"},{"key":"10.1111\/apt.13497-BIB0209|apt13497-cit-0209","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/ijms9101944","article-title":"DNA mimics for the rapid identification of microorganisms by fluorescence in\u00a0situ hybridization (FISH)","volume":"9","author":"Cerqueira","year":"2008","journal-title":"Int J Mol Sci"},{"key":"10.1111\/apt.13497-BIB0210|apt13497-cit-0210","doi-asserted-by":"crossref","first-page":"f4587","DOI":"10.1136\/bmj.f4587","article-title":"Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy","volume":"347","author":"Gatta","year":"2013","journal-title":"BMJ"},{"key":"10.1111\/apt.13497-BIB0211|apt13497-cit-0211","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00535-011-0487-6","article-title":"A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan","volume":"47","author":"Fujioka","year":"2011","journal-title":"J Gastroenterol"},{"issue":"Suppl. 1","key":"10.1111\/apt.13497-BIB0212|apt13497-cit-0212","doi-asserted-by":"crossref","first-page":"I40","DOI":"10.1136\/gut.45.2008.i40","article-title":"Treatment after failure: the problem of \u201cnon-responders\u201d","volume":"45","author":"Huang","year":"1999","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0213|apt13497-cit-0213","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1017\/S0950268814001770","article-title":"Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska","volume":"143","author":"Bruce","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1111\/apt.13497-BIB0214|apt13497-cit-0214","first-page":"A214","article-title":"Cag negative status of Helicobacter pylori is a risk factor for failure of PPI-based triple therapies in non-ulcer dyspepsia","volume":"114","author":"Marais","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.13497-BIB0215|apt13497-cit-0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gut.46.3.321","article-title":"Importance of Helicobacter pylori cagA and vacA\u00a0status for the efficacy of antibiotic treatment","volume":"46","author":"Doorn","year":"2000","journal-title":"Gut"},{"key":"10.1111\/apt.13497-BIB0216|apt13497-cit-0216","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.coph.2008.04.010","article-title":"New strategies for Helicobacter pylori eradication","volume":"8","author":"Selgrad","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/apt.13497-BIB0217|apt13497-cit-0217","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.13497","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apt.13497\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T09:45:02Z","timestamp":1653903902000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.13497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":217,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1111\/apt.13497","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726034993.793546699","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726034993.793520801","asserted-by":"object"}]},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}